WHO ICTRP trial
Safety and efficiacy of a new chickenpox and shingles vaccine in patients who…
EUCTR2019-002529-31-NO · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-002529-31-NO |
|---|---|
| Public title | Safety and efficiacy of a new chickenpox and shingles vaccine in patients who have undergone kidney transplantation |
| Scientific title | SAFETY AND EFFICACY OF SHINGRIX VACCINATION IN VARICELLA NAÏVE RENAL TRANSPLANT RECIPIENTS |
| Primary sponsor | Oslo University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Norway |
| Conditions | Kidney transplant recipients who are varicella-zoster sero-negative. The study aim to evaluate if the Shingrix vaccine will produce immune response in varicella naive kidney transplant recipients;Therapeutic area: Body processes [G]… |
| Interventions | Trade Name: Shingrix Product Name: Shingrix Pharmaceutical Form: Suspension for injection |
| Registration date | Nov 12, 2019 |
| Target size | 50 |
| Secondary IDs | VZVAC-TX |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: